Taiwan-based Medigen Vaccine Biologics Corp. said Thursday that 4,000 participants in three countries have been recruited for the Phase 3 clinical trial of its COVID-19 vaccine, which is being sponsored by the World Health Organization (WHO).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
A discussion with Cosette Wu, the woman behind the Harvard speech disruption
04/26/2024 11:25 PM - Society
32 indicted in NT$800 million crypto fraud case
04/26/2024 10:50 PM - Business
Taiwan, U.S. to hold new round of trade talks in Taipei next week: Office
04/26/2024 10:18 PM - Culture
Budapest picked as 2024 Taipei Film Festival's 'City in Focus'
04/26/2024 10:00 PM - Society
Constitutional Court rules public insult offense constitutional
04/26/2024 09:35 PM